Galien Bridges 2025 Award: A distinction for innovation in oncology
Servier has been awarded the inaugural 2025 Prix Galien Bridges Award for Best Product for Orphan/Rare Diseases on December 5th, during a ceremony held in Stockholm. The Prix Galien Bridges Award recognize life science innovation across the Nordic countries and their growing bridges with biopharmaceutical communities in key European and Middle Eastern countries, including Austria, Israel, The Netherlands, Portugal, and Spain.
Awards across multiple regions
We also won the Prix Galien USA Award in the same category, as well as the Prix Galien Poland Award. The Prix Galien Award recognizes breakthrough products and outstanding research teams across the pharmaceutical, biotech, medtech, and digital health fields.
“We are truly honored to receive these prestigious distinctions in several countries. It rewards Servier’s commitment to innovation and to patients as we continue to advance precision oncology for all who stand to benefit.”
Arnaud Lallouette, Executive Vice-President, Global Medical & Patient Affairs, Servier